viewSativa Group PLC

Sativa Group appoints new member to medical advisory board

Clive Page’s main research interests are in the pharmacology of inflammation and respiratory disease

Cannabis flowers in flasks
He is a professor of pharmacology at King's College London

Sativa Group PLC (LON:SATI) has appointed Clive Page, professor of pharmacology at King's College London, to its medical advisory board.

In a statement, the NEX-listed CBD wellness and medicinal cannabis company noted that Page’s main research interests are in the pharmacology of inflammation and respiratory disease, having published over 300 scientific papers and book chapters, and he is a fellow of the Royal Society of Biology and an honorary fellow of the British Pharmacological Society.

READ: Sativa inks exclusive deal with leading sales and marketing company for CBD range

Nick Horniman, director of regulatory affairs at Sativa commented: “Professor Page is an eminent research scientist and will add to Sativa's experience, interest and understanding in cannabis-based medical products."

Quick facts: Sativa Group PLC

Price: 4.25 GBX

Market: NEX
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Group PLC named herein, including the promotion by the Company of Sativa Group PLC in any Content on the Site, the Company receives from...



Full interview: Sativa Group is setting up for the future after Home Office...

Sativa Group (LON: SATI) CEO Henry Lees-Buckley joined Steve Darling from Proactive Vancouver to discuss the UK’s first listed Cannabis Company. This company focussing on 4 key business areas. Lee-Buckley talking about those areas and why he feels the UK is the right place at the right time...

on 5/11/19

2 min read